Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
Combining Celecoxib with Sorafenib Synergistically Inhibits Hepatocellular Carcinoma Cells In Vitro | Anticancer Research
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib | Journal of Experimental & Clinical Cancer Research | Full Text
Potential mechanism of HMGB1-induced sorafenib resistance in HCC.... | Download Scientific Diagram
Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant hepatocellular carcinoma cells
Sorafenib Pharmacodynamics
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology
Cancers | Free Full-Text | Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity | HTML
An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells – lncRNA Blog
Targeted therapy in HCC. Mechanisms of resistance to sorafenib in HCC... | Download Scientific Diagram
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects | Signal Transduction and Targeted Therapy
Scientists Identify Novel Adverse Effect and Mechanism of Sorafenib on Hepatocellular Carcinoma----Chinese Academy of Sciences
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
Making sorafenib irresistible: <i>In vivo</i> screening for mechanisms of therapy resistance in hepatocellular carci
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics
Frontiers | Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma | Oncology
Mechanism of action of sorafenib. Sorafenib inhibits the action of... | Download Scientific Diagram
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
